Stock Price Quote

MEDPLUS HEALTH SERVICES LTD.

NSE : MEDPLUSBSE : 543427ISIN CODE : INE804L01022Industry : Pharmaceuticals & DrugsHouse : Private
BSE768.854.3 (+0.56 %)
PREV CLOSE ( ) 764.55
OPEN PRICE ( ) 779.85
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4419
TODAY'S LOW / HIGH ( )762.50 779.85
52 WK LOW / HIGH ( )570 977.45
NSE768.855.95 (+0.78 %)
PREV CLOSE( ) 762.90
OPEN PRICE ( ) 768.00
BID PRICE (QTY) 768.85 (39)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 99041
TODAY'S LOW / HIGH( ) 762.35 774.90
52 WK LOW / HIGH ( )548.25 978
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 30-11 2006
Management Info
Gangadi Madhukar Reddy - Chairman Gangadi Madhukar Reddy - Managing Director
Registered Office

Address H. No: 11-6-56, Survey No: 257 & 258/1,Opp: I D P L Railway Siding Road,Moosapet, Kukatpally,
Hyderabad,
Telangana-500037

Phone 040-67246724

Email medplus@medplusindia.com

Website www.medplusindia.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE

NEWS

30Sep MedPlus Health Services informs about
MedPlus Health Services has informed that as per the Company’s Code of C..
01Sep Two entities sell shares worth Rs 1,20
Lavender Rose Investment and PI Opportunities Fund-I have offloaded shar..
28Aug Medplus Health Services informs about
Medplus Health Services has informed that pursuant to the amendment to t..
11Aug Medplus Health Services informs about
Medplus Health Services has informed that it disclosure under Regulation..
22Jun Hindustan Aeronautics, Tata Power and
Hindustan Aeronautics (HAL) has inked a memorandum of understanding (MoU..

Financials

in Millions
QTR Jun 23 ANNUAL 23
Net Profit-34.850000000000155.4400000000001
Gross Profit -34.8500000000001 75.8600000000001
Operating Profit 41.3099999999999294.38
Net Sales 718.922139.26

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  23159.10 (3.44%)
M.Cap ( in Cr)49211.47
Dr. Reddy's Lab (BSE)
peergroup  5586.75 (2.97%)
M.Cap ( in Cr)93178.48
Sanofi India (BSE)
peergroup  7206.50 (2.09%)
M.Cap ( in Cr)16597.02
Divi's Lab (BSE)
peergroup  3764.75 (2.75%)
M.Cap ( in Cr)99942.28
Alkem Laboratories (BSE)
peergroup  3607.65 (2.41%)
M.Cap ( in Cr)43134.87

Shareholding Pattern

PROMOTERS 40.43%
NON-INSTITUTION 26.57%
MUTUAL FUNDS/UTI 12.41%
FI/BANKS/INSURANCE 1.2%
GOVERNMENT 0%
FII 0%

About Medplus Health Services Ltd.

Medplus Health Services Ltd. was incorporated in the year 2006. Its today's share price is 768.85. Its current market capitalisation stands at Rs 9176.39 Cr. In the latest quarter, company has reported Gross Sales of Rs. 2308.55 Cr and Total Income of Rs.2371.09 Cr. The company's management includes Manoj Kumar Srivastava, Murali Sivaraman, Madhavan Ganesan, Anish Kumar Saraf, Hiroo Mirchandani, Gangadi Madhukar Reddy, Gangadi Madhukar Reddy.

It is listed on the BSE with a BSE Code of 543427 , NSE with an NSE Symbol of MEDPLUS and ISIN of INE804L01022. It's Registered office is at H. No: 11-6-56, Survey No: 257 & 258/1,Opp: I D P L Railway Siding Road,Moosapet, KukatpallyHyderabad-500037, Telangana. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are BSR & Associates, BSR & Associates LLP, SR Batliboi & Associates, SR Batliboi & Associates LLP, SR Batliboi & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.